Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-10

Clinical Trial Update: Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD [NA]

View source ↗

Summary

A Stanford-led clinical trial is exploring individualized neuroimaging biomarkers to predict response to repetitive transcranial magnetic stimulation for obsess…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Obsessive-Compulsive Disorder | NA | Status: ACTIVE_NOT_RECRUITING